Location History:
- Andhra Pradesh, IN (2014)
- Hyderabad, IN (2020 - 2022)
Company Filing History:
3 out of 20 
1 out of 2 Years Active: 2014-2022
Title: The Innovative Contributions of Radha Nagarapu
Introduction
Radha Nagarapu is a prominent inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative methods for synthesizing various compounds. With a total of four patents to his name, Nagarapu continues to push the boundaries of scientific research and development.
Latest Patents
One of his latest patents is titled "Method for the preparation of sulfobutylether beta cyclodextrin sodium." This invention relates to an improved method for synthesizing sulfobutylether beta cyclodextrin sodium, providing an amorphous form of the compound with a 1,4-butane sultone content of less than 0.5 ppm. Additionally, this patent ensures that the sulfobutylether beta cyclodextrin sodium contains less than 35 IU/g of bacterial endotoxins. Another notable patent is the "Method for the synthesis of ferric organic compounds," which focuses on an improved method for synthesizing Ferric Citrate. This invention also provides an amorphous form of Ferric Citrate with an active surface area of less than 14 sq.m/g.
Career Highlights
Nagarapu has worked with Biophore India Pharmaceuticals Pvt. Ltd. and Biophore India Pharmaceuticals Private Limited, where he has applied his expertise in pharmaceutical innovation. His work has contributed to advancements in drug formulation and delivery systems, showcasing his commitment to improving healthcare solutions.
Collaborations
Throughout his career, Nagarapu has collaborated with notable colleagues, including Manik Reddy Pullagurla and Jagadeesh Babu Rangisetty. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking inventions.
Conclusion
Radha Nagarapu's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a leading inventor. His work continues to impact the industry positively, paving the way for future advancements in drug synthesis and formulation.